TEVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teva Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 35.36 USD 1.58% Market Closed

Market Cap: $40.1B

	Teva Pharmaceutical Industries Ltd NYSE:TEVA	IL
O	Orient Overseas (International) Ltd XBER:ORI1	HK
M	Marriott International Inc XMUN:MAQ	US
	Mitsui O.S.K. Lines Ltd F:MIL	JP
	Cullinan Oncology Inc NASDAQ:CGEM	US

Profitability Summary

Teva Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

49% > 53%

Healthy Operating Margin

19%

Sustainable 3Y Average Operating Margin

22%

Declining Operating Margin

21% > 19%

Low Net Margin

Negative 3Y Average Net Margin

-2%

Net Margin is Increasing

-15% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

8% > 8%

Low ROE

10%

Negative 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

9% > 10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.